Development and comparison of mimotope-based immunoassays for the analysis of fumonisin B-1

: Riikka Peltomaa, Irene Agudo-Maestro, Vicente Más, Rodrigo Barderas, Elena Benito-Peña, María C. Moreno-Bondi

Publisher: SPRINGER HEIDELBERG

: 2019

Analytical and Bioanalytical Chemistry

: ANALYTICAL AND BIOANALYTICAL CHEMISTRY

: ANAL BIOANAL CHEM

: 411

: 26

: 6801

: 6811

: 11

: 1618-2642

DOI: https://doi.org/10.1007/s00216-019-02068-7

Mycotoxins can be found as natural contaminants in many foods and feeds, and owing to their toxic effects, it is essential to detect them before they enter the food chain. An interesting approach for the analysis of mycotoxins by competitive immunoassays is the use of epitope-mimicking peptides, or mimotopes, which can replace the toxin conjugates traditionally used in such assays. Mimotopes can be selected from phage-displayed peptide libraries even without any prior knowledge of the antibody-antigen interaction, and after identifying the target specific clones, individual clones can be efficiently amplified in bacteria and used directly in the immunoassay. Following such approach, we have previously selected and identified a dodecapeptide which functions as a mimotope for the mycotoxin fumonisin B-1. In this work, we present the development and comparison of various immunoassays based on this mimotope, named A2, which has been used in the phage-displayed format in which it was selected, but also as a fluorescent recombinant fusion protein or as a synthetic peptide. The highest sensitivity was obtained with a magnetic bead-based assay using the synthetic peptide and enzymatic detection which provided a detection limit of 0.029 ng mL(-1). Analysis of the binding kinetics by surface plasmon resonance (SPR) further reinforced the suitability of the synthetic peptide for the competitive immunoassays, as this mimotope showed a slightly lower affinity for the target antibody in comparison with the recombinant fusion protein.Graphical abstract